A type 2 diabetes-associated SNP in KCNQ1 (rs163184) modulates the binding activity of the locus for Sp3 and Lsd1/Kdm1a, potentially affecting CDKN1C expression
Masaki Hiramoto(Tokyo Medical University), Kazuki Yasuda(Kyorin University)
Cited by 15
Related Papers
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
|Molecular Pharmacology|1994|662
Comparative analysis of type 2 diabetes-associated SNP alleles identifies allele-specific DNA-binding proteins for the KCNQ1 locus
|International Journal of Molecular Medicine|2015|6
Glucocorticoid receptor-NECAB1 axis can negatively regulate insulin secretion in pancreatic β-cells
|Scientific Reports|2023|6